Anvisa simplifies registration and entry of Mpox vaccines

Anvisa has reissued a rule to simplify the process of registering and importing drugs and vaccines against Mpox. As a result, the Ministry of Health can request a waiver of registration for products that have already been approved by international regulatory authorities. The resolution, which is exceptional and temporary, aims to speed up the population’s access to these products in response to the Public Health Emergency of International Concern (PHEIC). Read more here

If you need more information on regulatory issues, ELS can certainly help.

Please do not hesitate to contact your local ELS consultant or via email info@elssolutions.pt

Contact us

We will contact you as soon as possible.